Preclinical evaluation of Mab CC188 for ovarian cancer imaging
International Journal of Cancer, 04/20/2012
Clinical Article
Xu M et al. – The authors work suggests that Mab CC188–based imaging and therapeutic reagents are capable of detecting early stage ovarian tumors and effectively treating the tumor.



